Inhibrx
INBX
INBX
92 hedge funds and large institutions have $151M invested in Inhibrx in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 36 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
-9
Holders Change %
-8.91%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
18
Reduced
36
Closed
15
Calls
$993K
Puts
$220K
Net Calls
+$773K
Net Calls Change
-$87K
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$5.01M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$4.25M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$2.39M |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$1.26M |
| 5 |
GLF
Groupe la Francaise
Paris,
France
|
+$1.06M |
Top Sellers
| 1 |
Walleye Capital
New York
|
-$8.93M |
| 2 |
CP
Castalian Partners
Excelsior,
Minnesota
|
-$2.95M |
| 3 |
SC
Slotnik Capital
Dallas,
Texas
|
-$1.41M |
| 4 |
Jane Street
New York
|
-$869K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$825K |
